Will there be a successful human trial of a vaccine for rheumatoid arthritis by the end of 2028?
Salud y medicinaOne-Off2a
Manifold MarketsSin KYCDatos de resolución verificadosCalibración aceptablePronóstico comunitario actualNo 79.8%
Pronosticadores
3
Tipo de pregunta
binary
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Datos de mercado
Actualizado hace 10 horas
Desactualizado22 may 23, 1:52 UTC1 ene 29, 4:59 UTC
Tendencias
Reglas
A team of researchers from the University of Toledo report that they were able to suppress the development of rheumatoid arthritis in rats by administering a vaccine containing the protein 14-3-3 zeta:
- https://www.thebrighterside.news/post/life-changing-vaccine-provides-long-lasting-protection-against-rheumatoid-arthritis
- The researchers have apparently filed for a patent for this concept and intend to pursue approval for early clinical trials in humans.
- Will their findings be reproduced in human trials?
- This will resolve YES if any clinical trial is performed to evaluate the efficacy of a vaccine for rheumatoid arthritis based on 14-3-3ζ before the end date, and the trial results show a statistically significant effect.
- Resolves NO otherwise.
